Ann: Algae.Tec Funding and Operational Update, page-41

I must say i agree with midmid's points wholeheartedly. It is impossible for aeb to please all its shareholders but at least its taking steps in the right direction. I've been following them a little while now and i believe 2018 may be one of their most profitable years. its a huge task for any company to diversify the way aeb has while still keeping their fingers in their original pies so i take may hat off to mal and the leadership.

btw did a bit of digging re Ma Genetics and if any one is familiar with the original 'landrace strains originating from the Netherlands' i would have to put 2 and 2 together and say  that they could indeed be Nevil’s Schoenmakers original seedbank from Holland. “A pioneer of the legal cannabis industry who has lobbied for its medicinal use in Australia, Schoenmakers is known as the father of Dutch seed banks, which transformed the plant’s cultivation by using genetics to create hybrids and cross-strains that could withstand the European climate.”(http://www.news.com.au/finance/busi...s/news-story/a132260a5a5f416decbcda616af405be)

If anyone has any idea of who Nevil is, an Australian/Dutch dual citizen who has a legendary cannabis breeding and goes by the nickname 'the king of cannabis' then there’s no doubt getting involved with a man like Nevil when entering into the Australian medical cannabis market will have huge benefits for aeb and place them at the fore front of the medical cannabis market here in Aus. If we can remember back to March and the announcement that sent Stemcell United's stock flying up 8300% in less than 48hrs when they advised that Nevil would be coming onboard as a strategic advisor. Looking forward to big things from aeb in the MC space aswell as their nutraceuticals. $$$$$$